Effects of physiotherapy techniques on painful points of trapezius muscle

The Effects of Manual Passive Muscle Shortening and Positional Release Therapy on Upper Trapezius Latent Myofascial Trigger Point: A randomized double blinded clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015100724412N1

Enrollment

Registered

2016-05-06

Start date

2016-05-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial trigger points-Myofascial pain syndrome. Disorder of muscle, unspecified

Interventions

Intervention 1: Control group: Subjects in this group will be treated by classical Positional Release Therapy. The subject will be in supine with therapist standing on the affected side. Pressure is a

Control group: Subjects in this group will be treated by classical Positional Release Therapy. The subject will be in supine with therapist standing on the affected side. Pressure is applied to the tr

Intervention group: Participants in this group will be treated by Manual Passive Muscle Shortening. The participant will be in prone position with therapist standing on the affected side. Origin and i

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18-35 years old; Subjects have to exhibit a latent trigger point in the upper trapezius muscle, either on the left or right side; Normal Body Mass Index (BMI); Local pain 3-7/10 on a visual analogue scale elicited by the application of 2.5 kg/cm2 of pressure with an algometer; Non athletic Exclusion criteria: Diagnosis of cervical radiculopathy or myelopathy determined by their primary care physician; Diagnosis of fibromyalgia syndrome; neck or shoulder surgery within the past year; Having undergone myofascial pain therapy in the cervical region within the past month before the study; Any sensory disturbances in the trapezius region.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Visual analogue scale. Timepoint: On first session before treatment, On third session five minutes after treatment, On follow up session one week after third session. Method of measurement: VAS ruler.;Pressure pain threshold. Timepoint: On first session before treatment, On third session five minutes after treatment, On follow up session one week after third session. Method of measurement: Algometer.;Active range of motion of lateral flexion. Timepoint: On first session before treatment, On third session five minutes after treatment, On follow up session one week after third session. Method of measurement: goniometer.	—

Measure

Time frame

Visual analogue scale. Timepoint: On first session before treatment, On third session five minutes after treatment, On follow up session one week after third session. Method of measurement: VAS ruler.;Pressure pain threshold. Timepoint: On first session before treatment, On third session five minutes after treatment, On follow up session one week after third session. Method of measurement: Algometer.;Active range of motion of lateral flexion. Timepoint: On first session before treatment, On third session five minutes after treatment, On follow up session one week after third session. Method of measurement: goniometer.

—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSakineh Goljaryan

Tabriz University of Medical Sciences

goljaryan@tbzmad.ac.ir+98 41 3331 1293

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026